{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:47:35Z","timestamp":1791881255040,"version":"4.3.4"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01993-8","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:35:24Z","timestamp":1791869724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood-based multiplex nanobiosensing of Alzheimer\u2019s disease biomarkers: from nanoengineered \u0131nterfaces to clinical translation"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5607-0728","authenticated-orcid":false,"given":"Zilan Nupelda","family":"Pehlivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3478-9754","authenticated-orcid":false,"given":"Kaan","family":"Z\u0131k\u015fahna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5494-2556","authenticated-orcid":false,"given":"Rumeysa","family":"Ad\u0131y\u0131l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0458-5638","authenticated-orcid":false,"given":"Murat","family":"Ihlamur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"1993_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnmol.2018.00164","volume":"11","author":"CM Abreu","year":"2018","unstructured":"Abreu CM et al (2018) Emerging biosensing technologies for neuroinflammatory and neurodegenerative disease diagnostics. Front Mol Neurosci 11:164","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"1993_CR2","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1007\/s12035-019-1501-x","volume":"56","author":"C Agliardi","year":"2019","unstructured":"Agliardi C et al (2019) SNAP-25 in serum is carried by exosomes of neuronal origin and is a potential biomarker of Alzheimer\u2019s disease. Mol Neurobiol 56(8):5792\u20135798","journal-title":"Mol Neurobiol"},{"issue":"24","key":"1993_CR3","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1007\/s00216-025-06061-1","volume":"417","author":"M Amiri","year":"2025","unstructured":"Amiri M et al (2025) A critical review on neurodegenerative biomarker diagnostics: where is the field heading to? Anal Bioanal Chem 417(24):5435\u20135448","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"1993_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JAD-160573","volume":"55","author":"SP Arneri\u0107","year":"2017","unstructured":"Arneri\u0107 SP et al (2017) Cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: a view of the regulatory science qualification landscape from the Coalition Against Major Diseases CSF Biomarker Team. J Alzheimers Dis 55(1):19\u201335","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"1993_CR5","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","volume":"91","author":"AJ Aschenbrenner","year":"2018","unstructured":"Aschenbrenner AJ et al (2018) Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology 91(9):e859\u2013e866","journal-title":"Neurology"},{"issue":"4","key":"1993_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/14789450.2017.1304217","volume":"14","author":"F Baldacci","year":"2017","unstructured":"Baldacci F et al (2017) Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer\u2019s disease and other neurodegenerative diseases. Expert Rev Proteomics 14(4):285\u2013299","journal-title":"Expert Rev Proteomics"},{"issue":"1","key":"1993_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-024-01391-1","volume":"16","author":"D Bali","year":"2024","unstructured":"Bali D, Hansson O, Janelidze S (2024) Effects of certain pre-analytical factors on the performance of plasma phospho-tau217. Alzheimers Res Ther 16(1):31","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"1993_CR8","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1021\/acssensors.1c00704","volume":"6","author":"AI Barbosa","year":"2021","unstructured":"Barbosa AI, Edwards AD, Reis NM (2021) Antibody surface coverage drives matrix interference in microfluidic capillary immunoassays. ACS Sens 6(7):2682\u20132690","journal-title":"ACS Sens"},{"issue":"12","key":"1993_CR9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet AL et al (2021) Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol 78(12):1471\u20131483","journal-title":"JAMA Neurol"},{"key":"1993_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bios.2015.01.060","volume":"68C","author":"A Biela","year":"2015","unstructured":"Biela A et al (2015) Disposable MMP-9 sensor based on the degradation of peptide cross-linked hydrogel films using electrochemical impedance spectroscopy. Biosens Bioelectron 68C:660\u2013667","journal-title":"Biosens Bioelectron"},{"key":"1993_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.impact.2020.100251","volume":"20","author":"M Bilal","year":"2020","unstructured":"Bilal M et al (2020) Nanomaterials for the treatment and diagnosis of Alzheimer\u2019s disease: an overview. NanoImpact 20:100251","journal-title":"NanoImpact"},{"issue":"5","key":"1993_CR12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jalz.2019.01.004","volume":"15","author":"I Bos","year":"2019","unstructured":"Bos I et al (2019) Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer\u2019s disease spectrum. Alzheimers Dement 15(5):644\u2013654","journal-title":"Alzheimers Dement"},{"key":"1993_CR13","doi-asserted-by":"crossref","unstructured":"Cao Y et al (2024) New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer\u2019s disease. Front Neurosci 18:1430465","DOI":"10.3389\/fnins.2024.1430465"},{"issue":"12","key":"1993_CR14","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3390\/nano9121663","volume":"9","author":"P Carneiro","year":"2019","unstructured":"Carneiro P, Morais S, Pereira MC (2019) Nanomaterials towards biosensing of Alzheimer\u2019s disease biomarkers. Nanomaterials 9(12):1663","journal-title":"Nanomaterials"},{"key":"1993_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/nano9121663","author":"P Carneiro","year":"2019","unstructured":"Carneiro P, Morais S, Pereira MC (2019) Nanomaterials towards biosensing of Alzheimer\u2019s disease biomarkers. Nanomaterials (Basel). https:\/\/doi.org\/10.3390\/nano9121663","journal-title":"Nanomaterials (Basel)"},{"issue":"4","key":"1993_CR16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/alz.12724","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P et al (2023) Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: a cross-sectional and longitudinal study in the AIBL cohort. Alzheimers Dement 19(4):1117\u20131134","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1993_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0169-328X(95)00257-S","volume":"36","author":"JE Cheetham","year":"1996","unstructured":"Cheetham JE et al (1996) Gap-43 message levels in anterior cerebellum in Alzheimer\u2019s disease. Brain Res Mol Brain Res 36(1):145\u2013151","journal-title":"Brain Res Mol Brain Res"},{"issue":"23","key":"1993_CR18","doi-asserted-by":"publisher","first-page":"7654","DOI":"10.1039\/D0AN01201G","volume":"145","author":"JS Chen","year":"2020","unstructured":"Chen JS et al (2020) A localized surface plasmon resonance (LSPR) sensor integrated automated microfluidic system for multiplex inflammatory biomarker detection. Analyst 145(23):7654\u20137661","journal-title":"Analyst"},{"issue":"7","key":"1993_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29071478","volume":"29","author":"H Chen","year":"2024","unstructured":"Chen H et al (2024) Neuroinflammation of microglial regulation in Alzheimer\u2019s disease: therapeutic approaches. Molecules 29(7):1478","journal-title":"Molecules"},{"issue":"11","key":"1993_CR20","doi-asserted-by":"publisher","first-page":"e2303509","DOI":"10.1002\/adhm.202303509","volume":"13","author":"JNY Costa","year":"2024","unstructured":"Costa JNY et al (2024) Single-response duplexing of electrochemical label-free biosensor from the same tag. Adv Healthc Mater 13(11):e2303509","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"1993_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF02815094","volume":"27","author":"P Davidsson","year":"1996","unstructured":"Davidsson P et al (1996) Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease? Mol Chem Neuropathol 27(2):195\u2013210","journal-title":"Mol Chem Neuropathol"},{"issue":"11","key":"1993_CR22","doi-asserted-by":"publisher","first-page":"e70867","DOI":"10.1002\/alz.70867","volume":"21","author":"C Delaby","year":"2025","unstructured":"Delaby C et al (2025) Impact of preanalytical delay on the performance of plasma A\u03b242, A\u03b242\/40, p-tau217, and p-tau217\/A\u03b242 in detecting brain amyloidosis in the ALZAN cohort. Alzheimers Dement 21(11):e70867","journal-title":"Alzheimers Dement"},{"issue":"10","key":"1993_CR23","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00018-019-03040-5","volume":"76","author":"K Dhiman","year":"2019","unstructured":"Dhiman K et al (2019) Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer\u2019s disease pathogenesis. Cell Mol Life Sci 76(10):1833\u20131863","journal-title":"Cell Mol Life Sci"},{"key":"1993_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","volume":"82","author":"LY Di Marco","year":"2015","unstructured":"Di Marco LY et al (2015) Vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease--a review of endothelium-mediated mechanisms and ensuing vicious circles. Neurobiol Dis 82:593\u2013606","journal-title":"Neurobiol Dis"},{"key":"1993_CR25","doi-asserted-by":"publisher","first-page":"117087","DOI":"10.1016\/j.trac.2023.117087","volume":"164","author":"M Ding","year":"2023","unstructured":"Ding M et al (2023) Recent advances in electrochemical biosensors for the detection of A\u03b242, a biomarker for Alzheimer disease diagnosis. TrAC Trends Anal Chem 164:117087","journal-title":"TrAC Trends Anal Chem"},{"issue":"71","key":"1993_CR26","doi-asserted-by":"publisher","first-page":"13359","DOI":"10.1039\/D5CC02322J","volume":"61","author":"N Docherty","year":"2025","unstructured":"Docherty N et al (2025) Maximising the translation potential of electrochemical biosensors. Chem Commun (Camb) 61(71):13359\u201313377","journal-title":"Chem Commun (Camb)"},{"key":"1993_CR27","doi-asserted-by":"crossref","unstructured":"Doecke JD et al (2025) Diagnostic performance of plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer\u2019s disease and non-AD dementias: an international multi-center study. Alzheimers Dement 21(6):e14573","DOI":"10.1002\/alz.14573"},{"issue":"1","key":"1993_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","volume":"15","author":"B Dubois","year":"2023","unstructured":"Dubois B et al (2023) Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants. Alzheimers Res Ther 15(1):175","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"1993_CR30","volume":"2","author":"X Fang","year":"2024","unstructured":"Fang X et al (2024) Bead-based microfluidic platforms for multiplex and ultrasensitive immunoassays in clinical diagnosis and treatment. Mech Med 2(2):100063","journal-title":"Mech Med"},{"issue":"2","key":"1993_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbm.2024.100063","volume":"2","author":"X Fang","year":"2024","unstructured":"Fang X et al (2024) Bead-based microfluidic platforms for multiplex and ultrasensitive immunoassays in clinical diagnosis and treatment. Mechanobiol Med 2(2):100063","journal-title":"Mechanobiol Med"},{"issue":"9","key":"1993_CR32","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.1002\/alz.14140","volume":"20","author":"DJ Figdore","year":"2024","unstructured":"Figdore DJ et al (2024) Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays. Alzheimers Dement 20(9):6506\u20136516","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1993_CR33","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/S0731-7085(99)00244-7","volume":"21","author":"JW Findlay","year":"2000","unstructured":"Findlay JW et al (2000) Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal 21(6):1249\u20131273","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"1993_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/prca.200900217","volume":"4","author":"Q Fu","year":"2010","unstructured":"Fu Q et al (2010) Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl 4(3):271\u2013284","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"1993_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsamd.2024.100694","volume":"9","author":"Y Fu","year":"2024","unstructured":"Fu Y et al (2024) Applications of nanomaterial technology in biosensing. J Sci Adv Mater Devices 9(2):100694","journal-title":"J Sci Adv Mater Devices"},{"key":"1993_CR36","doi-asserted-by":"publisher","first-page":"e00189","DOI":"10.1016\/j.plabm.2020.e00189","volume":"22","author":"H Furuya","year":"2020","unstructured":"Furuya H et al (2020) Analytical validation of ONCURIA\u2122 a multiplex bead-based immunoassay for the non-invasive bladder cancer detection. Pract Lab Med 22:e00189","journal-title":"Pract Lab Med"},{"key":"1993_CR29","unstructured":"GBD 2019 Dementia Forecasting Collaborators (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7(2):e105\u2013e125"},{"key":"1993_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114050","volume":"203","author":"B Gil Rosa","year":"2022","unstructured":"Gil Rosa B et al (2022) Multiplexed immunosensors for point-of-care diagnostic applications. Biosens Bioelectron 203:114050","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"1993_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JAD-150060","volume":"47","author":"M Groblewska","year":"2015","unstructured":"Groblewska M et al (2015) The role of visinin-like protein-1 in the pathophysiology of Alzheimer\u2019s disease. J Alzheimers Dis 47(1):17\u201332","journal-title":"J Alzheimers Dis"},{"issue":"18","key":"1993_CR39","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","volume":"111","author":"H Hampel","year":"2023","unstructured":"Hampel H et al (2023) Blood-based biomarkers for Alzheimer\u2019s disease: current state and future use in a transformed global healthcare landscape. Neuron 111(18):2781\u20132799","journal-title":"Neuron"},{"issue":"1","key":"1993_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","volume":"11","author":"O Hansson","year":"2019","unstructured":"Hansson O et al (2019) Advantages and disadvantages of the use of the CSF amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s disease. Alzheimers Res Ther 11(1):34","journal-title":"Alzheimers Res Ther"},{"key":"1993_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.878942","volume":"9","author":"N Hendrikse","year":"2022","unstructured":"Hendrikse N et al (2022) Biomarkers in medicines development\u2014from discovery to regulatory qualification and beyond. Front Med 9:878942","journal-title":"Front Med"},{"key":"1993_CR42","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3389\/fmolb.2021.674747","volume":"8","author":"CC Hoyt","year":"2021","unstructured":"Hoyt CC (2021) Multiplex immunofluorescence and multispectral imaging: forming the basis of a clinical test platform for immuno-oncology. Front Mol Biosci 8:2021","journal-title":"Front Mol Biosci"},{"key":"1993_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2021.113881","volume":"199","author":"S Hu","year":"2022","unstructured":"Hu S et al (2022) Nanozyme sensor array based on manganese dioxide for the distinction between multiple amyloid \u03b2 peptides and their dynamic aggregation process. Biosens Bioelectron 199:113881","journal-title":"Biosens Bioelectron"},{"issue":"3","key":"1993_CR44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5582\/ddt.2025.01055","volume":"19","author":"S Hu","year":"2025","unstructured":"Hu S, Yu H, Gao J (2025) The pTau217\/A\u03b2(1\u201342) plasma ratio: the first FDA-cleared blood biomarker test for diagnosis of Alzheimer\u2019s disease. Drug Discov Ther 19(3):208\u2013209","journal-title":"Drug Discov Ther"},{"key":"1993_CR45","doi-asserted-by":"publisher","first-page":"1029428","DOI":"10.3389\/fbioe.2022.1029428","volume":"10","author":"Z Huang","year":"2022","unstructured":"Huang Z et al (2022) Electrochemical immunosensor based on superwettable microdroplet array for detecting multiple Alzheimer\u2019s disease biomarkers. Front Bioeng Biotechnol 10:1029428","journal-title":"Front Bioeng Biotechnol"},{"key":"1993_CR46","doi-asserted-by":"crossref","unstructured":"Huang Z et al (2022) Electrochemical immunosensor based on superwettable microdroplet array for detecting multiple Alzheimer\u2019s disease biomarkers. Front Bioeng Biotechnol 10:2022","DOI":"10.3389\/fbioe.2022.1029428"},{"issue":"1","key":"1993_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12248-015-9820-y","volume":"18","author":"D Jani","year":"2016","unstructured":"Jani D et al (2016) Recommendations for use and fit-for-purpose validation of biomarker multiplex ligand binding assays in drug development. AAPS J 18(1):1\u201314","journal-title":"AAPS J"},{"issue":"8087","key":"1993_CR48","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/d41586-025-03394-w","volume":"646","author":"K Kavanagh","year":"2025","unstructured":"Kavanagh K (2025) Blood tests are now approved for Alzheimer\u2019s: how accurate are they? Nature 646(8087):1031\u20131032","journal-title":"Nature"},{"issue":"39","key":"1993_CR49","doi-asserted-by":"publisher","first-page":"e2201401","DOI":"10.1002\/smll.202201401","volume":"18","author":"S Kawakita","year":"2022","unstructured":"Kawakita S et al (2022) Organ-on-a-chip models of the blood-brain barrier: recent advances and future prospects. Small 18(39):e2201401","journal-title":"Small"},{"issue":"1","key":"1993_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41467-019-13901-z","volume":"11","author":"K Kim","year":"2020","unstructured":"Kim K et al (2020) Clinically accurate diagnosis of Alzheimer\u2019s disease via multiplexed sensing of core biomarkers in human plasma. Nat Commun 11(1):119","journal-title":"Nat Commun"},{"key":"1993_CR51","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.trci.2018.10.003","volume":"4","author":"BE Kirsebom","year":"2018","unstructured":"Kirsebom BE et al (2018) Cerebrospinal fluid neurogranin\/\u03b2-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement Transl Res Clin Interv 4:617\u2013627","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"1993_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102599","volume":"104","author":"HK Krishnamurthy","year":"2025","unstructured":"Krishnamurthy HK et al (2025) An overview of the genes and biomarkers in Alzheimer\u2019s disease. Ageing Res Rev 104:102599","journal-title":"Ageing Res Rev"},{"key":"1993_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.talo.2024.100327","volume":"9","author":"MR Kumalasari","year":"2024","unstructured":"Kumalasari MR, Alfanaar R, Andreani AS (2024) Gold nanoparticles (AuNPs): a versatile material for biosensor application. Talanta Open 9:100327","journal-title":"Talanta Open"},{"issue":"1","key":"1993_CR54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/jnc.15757","volume":"165","author":"C Kurz","year":"2023","unstructured":"Kurz C et al (2023) Impact of pre-analytical sample handling factors on plasma biomarkers of Alzheimer\u2019s disease. J Neurochem 165(1):95\u2013105","journal-title":"J Neurochem"},{"issue":"11","key":"1993_CR55","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/bios13110987","volume":"13","author":"PG Le","year":"2023","unstructured":"Le PG, Choi SH, Cho S (2023) Alzheimer\u2019s disease biomarker detection using field effect transistor-based biosensor. Biosensors 13(11):987","journal-title":"Biosensors"},{"issue":"2","key":"1993_CR56","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3233\/JAD-160722","volume":"55","author":"P Lewczuk","year":"2017","unstructured":"Lewczuk P et al (2017) Cerebrospinal fluid A\u03b242\/40 corresponds better than A\u03b242 to amyloid PET in Alzheimer\u2019s disease. J Alzheimers Dis 55(2):813\u2013822","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"1993_CR57","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/bios13080758","volume":"13","author":"M Li","year":"2023","unstructured":"Li M et al (2023) Vertical graphene-based printed electrochemical biosensor for simultaneous detection of four Alzheimer\u2019s disease blood biomarkers. Biosensors (Basel)13(8):758. https:\/\/doi.org\/10.3390\/bios13080758","journal-title":"Biosensors (Basel)"},{"key":"1993_CR58","doi-asserted-by":"publisher","first-page":"102922","DOI":"10.1016\/j.eti.2022.102922","volume":"28","author":"G Liang","year":"2022","unstructured":"Liang G et al (2022) Development of the screen-printed electrodes: a mini review on the application for pesticide detection. Environ Technol Innov 28:102922","journal-title":"Environ Technol Innov"},{"issue":"11","key":"1993_CR59","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/brain\/awaa286","volume":"143","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren N et al (2020) Longitudinal plasma p-tau217 is increased in early stages of Alzheimer\u2019s disease. Brain 143(11):3234\u20133241","journal-title":"Brain"},{"issue":"4","key":"1993_CR60","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00415-023-12148-5","volume":"271","author":"AJ Mendes","year":"2024","unstructured":"Mendes AJ et al (2024) Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort. J Neurol 271(4):2053\u20132066","journal-title":"J Neurol"},{"issue":"3","key":"1993_CR61","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/cells8030230","volume":"8","author":"A Mendsaikhan","year":"2019","unstructured":"Mendsaikhan A, Tooyama I, Walker DG (2019) Microglial progranulin: involvement in Alzheimer\u2019s disease and neurodegenerative diseases. Cells (Basel)8(3):230. https:\/\/doi.org\/10.3390\/cells8030230","journal-title":"Cells (Basel)"},{"issue":"8","key":"1993_CR62","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM et al (2018) Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement 14(8):989\u2013997","journal-title":"Alzheimers Dement"},{"key":"1993_CR63","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419888819","volume":"12","author":"M Mil\u00e0-Alom\u00e0","year":"2019","unstructured":"Mil\u00e0-Alom\u00e0 M, Su\u00e1rez-Calvet M, Molinuevo JL (2019) Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer\u2019s disease. Ther Adv Neurol Disord 12:1756286419888819","journal-title":"Ther Adv Neurol Disord"},{"issue":"9","key":"1993_CR64","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41591-022-01925-w","volume":"28","author":"M Mil\u00e0-Alom\u00e0","year":"2022","unstructured":"Mil\u00e0-Alom\u00e0 M et al (2022) Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease. Nat Med 28(9):1797\u20131801","journal-title":"Nat Med"},{"issue":"5","key":"1993_CR65","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jalz.2014.08.099","volume":"11","author":"SE O\u2019Bryant","year":"2015","unstructured":"O\u2019Bryant SE et al (2015) Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer\u2019s disease research. Alzheimers Dement 11(5):549\u2013560","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1993_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13195-016-0208-8","volume":"8","author":"A \u00d6hrfelt","year":"2016","unstructured":"\u00d6hrfelt A et al (2016) The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer\u2019s disease. Alzheimers Res Ther 8(1):41","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"1993_CR68","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3390\/s21062067","volume":"21","author":"MP Oyarz\u00fan","year":"2021","unstructured":"Oyarz\u00fan MP et al (2021) Plasmonic nanoparticles as optical sensing probes for the detection of Alzheimer\u2019s disease. Sensors (Basel) 21(6):2067. https:\/\/doi.org\/10.3390\/s21062067","journal-title":"Sensors (Basel)"},{"issue":"8","key":"1993_CR69","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S et al (2020) Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324(8):772\u2013781","journal-title":"JAMA"},{"issue":"4","key":"1993_CR70","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/alz.12751","volume":"19","author":"S Palmqvist","year":"2023","unstructured":"Palmqvist S et al (2023) An accurate fully automated panel of plasma biomarkers for Alzheimer\u2019s disease. Alzheimers Dement 19(4):1204\u20131215","journal-title":"Alzheimers Dement"},{"key":"1993_CR71","doi-asserted-by":"crossref","unstructured":"Palmqvist S et al (2025) Alzheimer\u2019s Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer\u2019s disease within specialized care settings. Alzheimers Dement 21(7):e70535","DOI":"10.1002\/alz.70535"},{"issue":"3","key":"1993_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2024.130559","volume":"1868","author":"A Panghal","year":"2024","unstructured":"Panghal A, Flora SJS (2024) Nanotechnology in the diagnostic and therapy for Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA) - General Subjects 1868(3):130559","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"issue":"2","key":"1993_CR73","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3233\/JAD-230384","volume":"95","author":"D Panikkar","year":"2023","unstructured":"Panikkar D et al (2023) Pre-analytical variables influencing stability of blood-based biomarkers of neuropathology. J Alzheimers Dis 95(2):735\u2013748","journal-title":"J Alzheimers Dis"},{"key":"1993_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112505","volume":"167","author":"D Park","year":"2020","unstructured":"Park D et al (2020) Multiplexed femtomolar detection of Alzheimer\u2019s disease biomarkers in biofluids using a reduced graphene oxide field-effect transistor. Biosens Bioelectron 167:112505","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"1993_CR75","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13195-019-0549-1","volume":"11","author":"V P\u00e9rez-Grijalba","year":"2019","unstructured":"P\u00e9rez-Grijalba V et al (2019) Plasma A\u03b242\/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study. Alzheimers Res Ther 11(1):96","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1993_CR76","first-page":"e12099","volume":"12","author":"LL Raket","year":"2020","unstructured":"Raket LL et al (2020) Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer\u2019s disease. Alzheimers Dement (Amst) 12(1):e12099","journal-title":"Alzheimers Dement (Amst)"},{"key":"1993_CR77","first-page":"123","volume":"9","author":"J Rasmussen","year":"2019","unstructured":"Rasmussen J, Langerman H (2019) Alzheimer\u2019s disease - why we need early diagnosis. Degener Neurol Neuromuscul Dis 9:123\u2013130","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"1993_CR78","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnagi.2017.00148","volume":"9","author":"V Salvi","year":"2017","unstructured":"Salvi V et al (2017) Role of atypical chemokine receptors in microglial activation and polarization. Front Aging Neurosci 9:148","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1993_CR79","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jalz.2018.08.006","volume":"15","author":"\u00c5 Sandelius","year":"2019","unstructured":"Sandelius \u00c5 et al (2019) Elevated CSF GAP-43 is Alzheimer\u2019s disease specific and associated with tau and amyloid pathology. Alzheimers Dement 15(1):55\u201364","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1993_CR80","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1038\/s41467-022-30168-z","volume":"13","author":"J Seo","year":"2022","unstructured":"Seo J et al (2022) PICASSO allows ultra-multiplexed fluorescence imaging of spatially overlapping proteins without reference spectra measurements. Nat Commun 13(1):2475","journal-title":"Nat Commun"},{"issue":"7","key":"1993_CR81","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/bios13070742","volume":"13","author":"A Sharma","year":"2023","unstructured":"Sharma A et al (2023) Electrochemical immunosensors developed for amyloid-beta and tau proteins, leading biomarkers of Alzheimer\u2019s disease. Biosensors (Basel) 13(7):742","journal-title":"Biosensors (Basel)"},{"key":"1993_CR82","doi-asserted-by":"crossref","unstructured":"Sharma A et al (2023) Electrochemical immunosensors developed for amyloid-beta and tau proteins, leading biomarkers of Alzheimer\u2019s Disease. Biosensors (Basel) 13(7):742.","DOI":"10.3390\/bios13070742"},{"key":"1993_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2025.117216","volume":"274","author":"J-E Shim","year":"2025","unstructured":"Shim J-E et al (2025) Ultrasensitive SERS nanoprobe-based multiplexed digital sensing platform for the simultaneous quantification of Alzheimer\u2019s disease biomarkers. Biosens Bioelectron 274:117216","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"1993_CR84","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D (2022) Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammation 19(1):206","journal-title":"J Neuroinflammation"},{"key":"1993_CR85","doi-asserted-by":"crossref","unstructured":"Song S et al (2022) Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer\u2019s disease using label-free plasmonic biosensor based on DNA-assembled advanced plasmonic architecture. Biosens Bioelectron 199:113864","DOI":"10.1016\/j.bios.2021.113864"},{"key":"1993_CR86","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jconrel.2023.07.004","volume":"360","author":"N Song","year":"2023","unstructured":"Song N et al (2023) Emerging nanotechnology for Alzheimer\u2019s disease: from detection to treatment. J Control Release 360:392\u2013417","journal-title":"J Control Release"},{"issue":"12","key":"1993_CR87","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809712","volume":"10","author":"M Su\u00e1rez-Calvet","year":"2018","unstructured":"Su\u00e1rez-Calvet M et al (2018) CSF progranulin increases in the course of Alzheimer\u2019s disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Mol Med 10(12):e9712. https:\/\/doi.org\/10.15252\/emmm.201809712","journal-title":"EMBO Mol Med"},{"key":"1993_CR88","doi-asserted-by":"publisher","first-page":"125063","DOI":"10.1016\/j.talanta.2023.125063","volume":"266","author":"Y Sun","year":"2024","unstructured":"Sun Y et al (2024) Potential-resolved electrochemiluminescence biosensor for simultaneous determination of multiplex miRNA. Talanta 266:125063","journal-title":"Talanta"},{"issue":"9","key":"1993_CR89","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1474-4422(25)00227-3","volume":"24","author":"J Therriault","year":"2025","unstructured":"Therriault J et al (2025) Blood phosphorylated tau for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 24(9):740\u2013752","journal-title":"Lancet Neurol"},{"issue":"1","key":"1993_CR90","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/acn3.51695","volume":"10","author":"TF Tropea","year":"2023","unstructured":"Tropea TF et al (2023) Plasma phosphorylated tau181 predicts cognitive and functional decline. Ann Clin Transl Neurol 10(1):18\u201331","journal-title":"Ann Clin Transl Neurol"},{"key":"1993_CR91","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fnano.2024.1348308","volume":"6","author":"F Ulucan-Karnak","year":"2024","unstructured":"Ulucan-Karnak F, Kuru C\u0130, Akg\u00f6l S (2024) Commercial roadmap of nanobiosensor development. Front Nanotechnol 6:2024","journal-title":"Front Nanotechnol"},{"issue":"9","key":"1993_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/celc.202200055","volume":"9","author":"A Valverde","year":"2022","unstructured":"Valverde A et al (2022) Paving the way for reliable Alzheimer\u2019s disease blood diagnosis by quadruple electrochemical immunosensing. ChemElectroChem 9(9):e202200055","journal-title":"ChemElectroChem"},{"issue":"9","key":"1993_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201205","volume":"13","author":"KE van Meijgaarden","year":"2018","unstructured":"van Meijgaarden KE et al (2018) Cross-laboratory evaluation of multiplex bead assays including independent common reference standards for immunological monitoring of observational and interventional human studies. PLoS ONE 13(9):e0201205","journal-title":"PLoS ONE"},{"issue":"8","key":"1993_CR94","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/alz.12510","volume":"18","author":"IMW Verberk","year":"2022","unstructured":"Verberk IMW et al (2022) Characterization of pre-analytical sample handling effects on a panel of Alzheimer\u2019s disease-related blood-based biomarkers: results from the Standardization of Alzheimer\u2019s Blood Biomarkers (SABB) working group. Alzheimers Dement 18(8):1484\u20131497","journal-title":"Alzheimers Dement"},{"key":"1993_CR95","doi-asserted-by":"crossref","unstructured":"Wang J et al (2025) Diagnostic accuracy of plasma p-tau217\/A\u03b242 for Alzheimer\u2019s disease in clinical and community cohorts. Alzheimers Dement 21(3):e70038","DOI":"10.1002\/alz.70038"},{"issue":"1","key":"1993_CR96","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12883-019-1591-0","volume":"20","author":"C Wattmo","year":"2020","unstructured":"Wattmo C, Blennow K, Hansson O (2020) Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer\u2019s disease. BMC Neurol 20(1):10","journal-title":"BMC Neurol"},{"issue":"19","key":"1993_CR97","doi-asserted-by":"publisher","DOI":"10.1172\/JCI198725","volume":"135","author":"JK Wisch","year":"2025","unstructured":"Wisch JK, Ances BM (2025) Ruling in, ruling out: the clinical utility of plasma biomarkers in diagnosis of Alzheimer\u2019s disease. J Clin Invest 135(19):e198725. https:\/\/doi.org\/10.1172\/JCI198725","journal-title":"J Clin Invest"},{"issue":"5","key":"1993_CR98","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/s17050965","volume":"17","author":"P Y\u00e1\u00f1ez-Sede\u00f1o","year":"2017","unstructured":"Y\u00e1\u00f1ez-Sede\u00f1o P, Campuzano S, Pingarr\u00f3n JM (2017) Multiplexed electrochemical immunosensors for clinical biomarkers. Sensors (Basel) 17(5):965","journal-title":"Sensors (Basel)"},{"issue":"4","key":"1993_CR99","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/JAD-170810","volume":"61","author":"CC Yang","year":"2018","unstructured":"Yang CC et al (2018) Assay of plasma phosphorylated tau protein (threonine 181) and total tau protein in early-stage Alzheimer\u2019s disease. J Alzheimers Dis 61(4):1323\u20131332","journal-title":"J Alzheimers Dis"},{"key":"1993_CR100","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2147\/IJN.S293042","volume":"16","author":"D Yu","year":"2021","unstructured":"Yu D et al (2021) SERS-based immunoassay enhanced with silver probe for selective separation and detection of Alzheimer\u2019s disease biomarkers. Int J Nanomedicine 16:1901\u20131911","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1993_CR101","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-024-00711-1","volume":"19","author":"X Zeng","year":"2024","unstructured":"Zeng X et al (2024) Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting. Mol Neurodegener 19(1):40","journal-title":"Mol Neurodegener"},{"key":"1993_CR102","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-018-0127-7","volume":"7","author":"H Zhang","year":"2018","unstructured":"Zhang H et al (2018) Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer\u2019s disease. Transl Neurodegener 7:23","journal-title":"Transl Neurodegener"},{"issue":"8","key":"1993_CR103","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1021\/acssensors.9b00974","volume":"4","author":"X Zhang","year":"2019","unstructured":"Zhang X et al (2019) Robust and universal SERS sensing platform for multiplexed detection of Alzheimer\u2019s disease core biomarkers using PAapt-AuNPs conjugates. ACS Sens 4(8):2140\u20132149","journal-title":"ACS Sens"},{"key":"1993_CR104","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fnagi.2018.00202","volume":"10","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Ulland TK, Colonna M (2018) TREM2-dependent effects on microglia in Alzheimer\u2019s disease. Front Aging Neurosci 10:202","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1993_CR105","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00604-021-04705-4","volume":"188","author":"X Zhou","year":"2021","unstructured":"Zhou X et al (2021) Colorimetric determination of amyloid-\u03b2 peptide using MOF-derived nanozyme based on porous ZnO-Co3O4 nanocages. Mikrochim Acta 188(2):56","journal-title":"Mikrochim Acta"},{"key":"1993_CR106","doi-asserted-by":"publisher","first-page":"102485","DOI":"10.1016\/j.arr.2024.102485","volume":"101","author":"Y Zou","year":"2024","unstructured":"Zou Y et al (2024) CSF and blood glial fibrillary acidic protein for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Ageing Res Rev 101:102485","journal-title":"Ageing Res Rev"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01993-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01993-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01993-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:02:18Z","timestamp":1791878538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01993-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1993"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01993-8","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, ChatGPT tools were used to improve readability. The authors reviewed and edited the content as needed and took full responsibility for the content of the publication.","order":5,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","label":"Conflicts of \u0131nterests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"234"}}